The ontogeny of 3,4-dihydroxyphenylacetic acid in human cerebrospinal fluid

G. M. Anderson, Mark A Riddle, E. L. Hoder, F. C. Feibel, B. A. Shaywitz, D. J. Cohen

Research output: Contribution to journalArticle

Abstract

Measurement of cerebrospinal fluid (CSF) levels of the minor dopamine metabolite 3,4-dihydroxyphenylacetic acid in neonates and children indicates that a rapid decline (approximately 90%) occurs in the first 2 years of life. The much less rapid ontogenetic decline seen for the predominant dopamine metabolite, homovanillic acid (HVA), indicates that differing factors affect CSF levels of the two acid metabolites. Further study is required to determine which compound more closely reflects ontogenetic changes in dopamine functioning.

Original languageEnglish (US)
Pages (from-to)1100-1102
Number of pages3
JournalJournal of Neurology Neurosurgery and Psychiatry
Volume51
Issue number8
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

3,4-Dihydroxyphenylacetic Acid
Cerebrospinal Fluid
Dopamine
Homovanillic Acid
Newborn Infant
Acids

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Psychiatry and Mental health
  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology

Cite this

The ontogeny of 3,4-dihydroxyphenylacetic acid in human cerebrospinal fluid. / Anderson, G. M.; Riddle, Mark A; Hoder, E. L.; Feibel, F. C.; Shaywitz, B. A.; Cohen, D. J.

In: Journal of Neurology Neurosurgery and Psychiatry, Vol. 51, No. 8, 1988, p. 1100-1102.

Research output: Contribution to journalArticle

Anderson, G. M. ; Riddle, Mark A ; Hoder, E. L. ; Feibel, F. C. ; Shaywitz, B. A. ; Cohen, D. J. / The ontogeny of 3,4-dihydroxyphenylacetic acid in human cerebrospinal fluid. In: Journal of Neurology Neurosurgery and Psychiatry. 1988 ; Vol. 51, No. 8. pp. 1100-1102.
@article{12941c02eba44dc98cbf791b110a93f0,
title = "The ontogeny of 3,4-dihydroxyphenylacetic acid in human cerebrospinal fluid",
abstract = "Measurement of cerebrospinal fluid (CSF) levels of the minor dopamine metabolite 3,4-dihydroxyphenylacetic acid in neonates and children indicates that a rapid decline (approximately 90{\%}) occurs in the first 2 years of life. The much less rapid ontogenetic decline seen for the predominant dopamine metabolite, homovanillic acid (HVA), indicates that differing factors affect CSF levels of the two acid metabolites. Further study is required to determine which compound more closely reflects ontogenetic changes in dopamine functioning.",
author = "Anderson, {G. M.} and Riddle, {Mark A} and Hoder, {E. L.} and Feibel, {F. C.} and Shaywitz, {B. A.} and Cohen, {D. J.}",
year = "1988",
doi = "10.1136/jnnp.51.8.1100",
language = "English (US)",
volume = "51",
pages = "1100--1102",
journal = "Journal of Neurology, Neurosurgery and Psychiatry",
issn = "0022-3050",
publisher = "BMJ Publishing Group",
number = "8",

}

TY - JOUR

T1 - The ontogeny of 3,4-dihydroxyphenylacetic acid in human cerebrospinal fluid

AU - Anderson, G. M.

AU - Riddle, Mark A

AU - Hoder, E. L.

AU - Feibel, F. C.

AU - Shaywitz, B. A.

AU - Cohen, D. J.

PY - 1988

Y1 - 1988

N2 - Measurement of cerebrospinal fluid (CSF) levels of the minor dopamine metabolite 3,4-dihydroxyphenylacetic acid in neonates and children indicates that a rapid decline (approximately 90%) occurs in the first 2 years of life. The much less rapid ontogenetic decline seen for the predominant dopamine metabolite, homovanillic acid (HVA), indicates that differing factors affect CSF levels of the two acid metabolites. Further study is required to determine which compound more closely reflects ontogenetic changes in dopamine functioning.

AB - Measurement of cerebrospinal fluid (CSF) levels of the minor dopamine metabolite 3,4-dihydroxyphenylacetic acid in neonates and children indicates that a rapid decline (approximately 90%) occurs in the first 2 years of life. The much less rapid ontogenetic decline seen for the predominant dopamine metabolite, homovanillic acid (HVA), indicates that differing factors affect CSF levels of the two acid metabolites. Further study is required to determine which compound more closely reflects ontogenetic changes in dopamine functioning.

UR - http://www.scopus.com/inward/record.url?scp=0023749418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023749418&partnerID=8YFLogxK

U2 - 10.1136/jnnp.51.8.1100

DO - 10.1136/jnnp.51.8.1100

M3 - Article

C2 - 3216215

AN - SCOPUS:0023749418

VL - 51

SP - 1100

EP - 1102

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

SN - 0022-3050

IS - 8

ER -